AIs Growing Influence on Quarterly Earnings A Broad Overview CBS Cancels The Late Show With Stephen Colbert Shifts LateNight Strategy India Government Plans Major Overhaul of Tax Administration to Facilitate Smooth GST Rollout The Pitfalls of Chasing Returns Why a Disciplined Investment Approach May Serve Better Social Security Strategy Weighing Early Claiming and Survivor Benefits at Age 62 General Compute Launches First ASICNative Neocloud for AI Agent Applications Cresud CRESY Q1 2026 Earnings Strong EPS Report Despite Modest Stock Decline Docebo Q1 2026 Earnings Narrow EPS Miss Positive Market Reception Despite Limited Disclosures Oil States International OIS Q1 2026 Earnings EPS Beat Fails to Lift Shares Editas Medicine Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment CNO Q1 2026 Earnings Strong Earnings Beat Amid Modest Stock Decline Marker Therapeutics Inc MRKR Q1 2026 Earnings EPS Beat Expectations Amid Development Stage Operations Orangekloud Technology ORKT Holds Near Support Amid Lightly Negative Session Energous Corporation WATT Edges Lower Amid Testing Key Support Levels Silicon Valley Acquisition Corp SVAQ Holds Steady at 995 Consolidation in the SPAC Sector Norfolk Southern NSC Gains 18 as Railroad Stock Holds Above Key Support Raymond James Financial RJF Slips 113 as Investors Weigh Resistance at 15083 Michael Saylor Tokenization May Create a Free Market in Credit and Yield Challenging Traditional Banking LNC Q1 2026 Earnings Earnings Beat Masks Cautious Outlook as Stock Slips Ucommune International Ltd UK Surges 411 Key Resistance Levels in Focus 1RT Acquisition Corp ONCH Holds Steady Near Resistance RangeBound Action Continues Cross Timbers Royalty Trust CRT Advances 16 as Trust Shares Find Support Near 1034 OmniAb Inc OABI Rallies 39 as Stock Tests Key Resistance Levels SPWRW Warrants Rally 778 as Stock Approaches Key 020 Resistance Manhattan Bridge Capital LOAN Holds Steady Near MidRange Despite Low Volume Knife Riv Holding Co KNF Surges 34 on Strong Volume Approaches Key Resistance Apogee Therapeutics APGE Edges Lower as Biotech Sentiment Wavers